Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

Technology Scientific & Technical Instruments
RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Deal signed
View:
Comment by psvbruceleefc on Jan 25, 2021 10:00am
Glad I'm holding my nerve on this one, learnt the hard way lately, I had shares in heat biologics bought them at 0.49 per share but lost faith and sold for a small profit. Share price today is nearly 6.00. I won't ever do that again. 
Comment by MetzGER on Jan 25, 2021 10:51am
CONGRATULATIONS BROS FOR PASSING THESE HARD TIMES TOGETHER. Now we Are Ready For Take off!!!
Comment by kalareta on Jan 25, 2021 11:24am
In 2014 this company was 9 dolllars per share. 
Comment by Ingiboy on Jan 25, 2021 11:23am
Another milestone day for Replicel.  It took a while but it's time to go to the next phase of development of this company. We now need TSX Venture Exchange approval of the deal.  Once that happens the first installment of money from Mainpointe will be transferred. I was hoping for a little more detail on the status of the Dermal Injector but I guess we wait for the Corporate Update ...more  
Replicel Life Sciences Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities